Full Breakdown
Billionaire Longevity Stacks Fuel East End Wellness Surge
5/28/2026, 11:04:23 AM
Core Longevity Stack: Ingredients and Typical Dosages
Bryan Johnson and David Sinclair publicly follow a core stack that includes nicotinamide mononucleotide (NMN) – 500 mg six days per week for Johnson and 1 g daily for Sinclair – resveratrol (1 g), spermidine (1–2 mg), fisetin (~500 mg), calcium-alpha-ketoglutarate, CoQ10 (100–200 mg), vitamin D3, vitamin K2, omega-3 fatty acids, and trimethylglycine (TMG). Metformin is added by some at $10-$30 per month.
Origins and Market Expansion in the Hamptons
Originally a Silicon Valley biohacking practice, the stack entered mainstream wellness through high-profile adopters such as Johnson, Sinclair, Daymond John, and Gwyneth Paltrow. By summer 2026, longevity-focused clinics on the South Fork—including Hamptons BioMed, Wellness IV Hamptons, and Concierge Wellness—offered NAD+ IV drips, peptide protocols, and exosome treatments alongside the oral stack, marking rapid regional market growth.
Pricing Overview of Supplements and Clinical Services
Third-party-tested NMN costs $50-$150 per month at a 1 g daily dose; resveratrol $20-$60; spermidine $30-$70; fisetin $20-$50; calcium-alpha-ketoglutarate $30-$60; CoQ10 $15-$40; vitamin D3 $5-$15. A full eight-compound stack totals $200-$400 monthly, while a starter stack (NMN, D3, omega-3, spermidine) runs $100-$195. NAD+ IV drips in the Hamptons average $500-$750 per 500 mg session; peptide consultations $300-$750 with monthly compound costs $100-$500; exosome sessions range $500-$5,000.
Official Statements from Leading Practitioners
David Sinclair publicly states that NMN supplementation doubles NAD+ levels in humans and that NMN is superior to nicotinamide riboside (NR) for raising NAD+. Bryan Johnson’s disclosed regimen includes 500 mg of NMN six days per week, 1–2 mg of spermidine, and additional compounds such as resveratrol and fisetin. Both emphasize a multi-pathway strategy that pairs NAD+ precursors with sirtuin activators, autophagy inducers, and senolytics.
Criticism, Evidence Gaps, and Conflicting Views
Human trials remain limited for most stack components; NMN and spermidine show promising animal data but lack long-term randomized studies. The FDA questioned NMN’s classification as a dietary supplement in 2022, noting its drug-development status. Researchers at NOVOS Labs argue that pterostilbene may surpass resveratrol due to better absorption, while others cite NR’s broader human trial record despite weaker lifespan evidence. Sinclair’s claim of NMN superiority contrasts with the unresolved debate over NAD+ precursors.
Impact on Longevity Economy and Female Adoption
Women control roughly 80 % of household healthcare spending and drive most longevity purchases on the East End. The Global Wellness Summit 2026 and Biohacking Index March 2026 reports label women as a defining trend, noting that female networks generate clinic bookings, supplement orders, and referrals. Average annual outlay for a female client ranges $12 000–$40 000, covering NAD+ infusions, a $200-$400 supplement stack, fitness programming, comprehensive labs, and periodic full-body MRI scans.
What’s Next for Longevity Services on the South Fork
The upcoming Polo Hamptons events (July 18 and 25, 2026) will showcase new longevity protocols. Industry forecasts anticipate growth in female-specific supplement formulations and hormone-optimization programs. Clinics such as Hamptons BioMed plan to expand peptide and exosome services, while consumer demand is expected to spur more rigorous clinical trials and evidence-based offerings.
